CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: Effects of celecoxib, alone or with imatinib, on colony formation of Ph+ cell lines (TKI-sensitive or resistant) and primary CD34+ CML and acute lymphoblastic leukemia (ALL) cells